A separate, simplified model compared the biologic dupilumab to PPI and tCS. The primary outcome was the incremental cost-effectiveness ratio (ICER) at 2- and 5-year time horizons. Treatment ...

Dupixent (dupilumab) is a prescription drug that ... Also, be sure to talk with your doctor about which drug is better for you. Costs of prescription drugs can vary depending on many factors.

Dupilumab users had at least 0.5 fewer exacerbations ... Overall increases in asthma-related costs associated with the use of these biologic treatments likely reflect the costs of these drugs ...

Dupilumab (Dupixent): This newer medication ... That’s lucky, since phototherapy regimens can cost several thousand dollars. Don’t let the costs of managing your atopic dermatitis treatment ...

additional costs applied to non-responders to account for the cost of treatment failure (see section 3.12). When taking into account the confidential discount for dupilumab, the company's base-case ...

"[W]hether dupilumab is better than the good old topical glucocorticoids in improving disease outcomes, particularly in light of considerable costs associated with [dupilumab] treatment, remains ...

Dupilumab had previously been shown to be effective in the treatment of atopic dermatitis, but this research is the first to examine the drug's efficacy in children with atopic dermatitis and co ...

Among the dupilumab treatment and placebo groups, 69% and 71% had previously used STCs, respectively. Dupilumab safely and efficaciously improved clinical, histologic, endoscopic, and symptomatic ...

Since its release in 2017, dupilumab (a fully humanized monoclonal antibody that blocks IL-4 and IL-13) has transformed the therapeutic landscape for managing atopic dermatitis (AD) and other ...